Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WAS ALREADY TO $5 IN JUST FEW HOURS AFTER TOUCHING THE $15
3 to 15 back to 4 in one day🥴
bought as low as 4.77 in the aftermarket. Will start selling somewhere in the $6 range if its hit, nothings guaranteed
well, finally finally we got some serious movement. Glad I bought all the way down to 2 bucks, it was painful, but I got used to the pain. I sold out 3/4 of my total position at various prices up to the top and started trading back in for a trading position. Raise a huge amount of cash. A number of these stocks go thru this craziness (BTTR, SXTP) where its algos doing all or most of the trading. At $8 I would be a buyer under that, and a seller over 10 bucks. What it does nobody I repeat nobody knows, you dont have to know, you just need to be alert, take profits, and buy back in at reasonable prices. Dont make it more complicated than that. I probably should have sold my entire position but heck, it just kept going, crazy really.
Pump/dump in effect
ALZN: INDEED!!! (Just wait until the proverbial SHIT-HITS-THE-FAN behind this SCAMMING-PR's company!!!)
MAKE THAT MONEY!!!
ALZN: IDENTICAL "news" --- biggest SCAM PR of the year!!! (Will be on "60-Minutes" shortly.)
MAKE THAT MONEY!!!
SAME NEWS???
Today 08:00AM
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
(Business Wire)
+530.91%
Aug-12-24 08:00AM
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
(Business Wire)
Aug-06-24 08:00AM
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a NextGeneration Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
(Business Wire)
-9.84%
05:32AM
Alzamend Neuro partners with Mass General for Alzheimers treatment trial
(Clinical Trials Arena)
imagine this goes back to its IPO price
how sick would that be
$33 ipo
CONGRAT$ YOU DID IT AGAIN
$ALZN OH MY pic.twitter.com/PBJXKCmsX7
— THE FINAL COUNTDOWN (@READY_2_PROFIT) August 19, 2024
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
$ALZN 08:00 on Aug. 19 2024
— NuntioBot (@NuntioBot) August 19, 2024
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
It has no value…
IPO @ $33
They have no product
Maybe but I am trying to give benefit of doubt that he is distanced from ruining the company and I continue to accumulate at great prices in my opinion.
This guy “Toddy” is a 1 man criminal enterprise destined for the greybar hotel.
I go way back to his Prudential phase…
A >99% loss in less than a year
It’s a total fraud
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
277
|
Created
|
06/16/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |